Enhanced stent visualization systems during PCI: A case series and review of literature  by Biscaglia, Simone et al.
Journal of Cardiology Cases 12 (2015) 1–5Case Report
Enhanced stent visualization systems during PCI:
A case series and review of literature
Simone Biscaglia (MD)a,*, Carlo Tumscitz (MD)a, Matteo Tebaldi (MD)a,
Elisa Andrenacci (MD)a, Rita Pavasini (MD)a, Gianluca Campo (MD)a,b,
Roberto Ferrari (MD, PhD)a,b,c
aCardiovascular Institute, Azienda Ospedaliera Universitaria S.Anna, Cona FE, Italy
b LTTA (Laboratorio per le Tecnologie delle Terapie Avanzate) Center, Ferrara, Italy
cMaria Cecilia Hospital, GVM Care & Research, E.S.: Health Science Foundation, Cotignola, Italy
A R T I C L E I N F O
Article history:
Received 6 January 2015
Received in revised form 3 February 2015
Accepted 18 February 2015
Keywords:






A B S T R A C T
Enhanced stent visualization systems increase the amount and quality of information during
percutaneous coronary interventions. When compared to imaging techniques such as intravascular
ultrasound and optical coherence tomography, enhanced stent visualization systems are easy-to-use, as
well as time and cost saving. They are useful during stent implantation, overlap, assessment of integrity,
and expansion. We review the available data regarding enhanced stent visualization systems and we
report 5 cases showing their current applications during percutaneous coronary interventions.
<Learning objective: Enhanced stent visualization (ESV) systems are helpful especially during complex
percutaneous coronary interventions (PCI). In everyday clinical practice, ESV systems can be used both
along with and instead of intracoronary imaging systems. The present case series show the main current
applications of ESV systems during complex PCI cases with a brief review of the available data.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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For decades visual assessment has been the only available tool
to evaluate the presence and severity of coronary stenoses, as well
as the results of percutaneous coronary interventions (PCI).
Nevertheless, it is well known that angiography alone cannot
provide to physicians sufﬁcient information in several clinical
scenarios (e.g. stent fracture assessment, acute and late stent
malapposition, overlapping stent placement). For the above-
mentioned reasons, alternative imaging techniques have been
developed to overcome some limitations of a mere visual
approach. Thus, now-a-days intravascular ultrasonography (IVUS)
and optical coherence tomography (OCT) provide a detailed
assessment of coronary artery anatomy and of atherosclerotic
plaque composition. These techniques are also useful in the* Corresponding author at: Cardiovascular Institute, Azienda Ospedaliera
Universitaria S.Anna, Via Aldo Moro 8, Cona (FE), Italy. Tel.: +39 0532 237227;
fax: +39 0532 236593.
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsevaluation of correct location and expansion of implanted stents.
On the other hand, IVUS and OCT present some ‘‘weak points’’.
Their use is limited in distal lesions or in vessels with severe
calciﬁcations or tortuosity and rare serious adverse complications
have been reported (e.g. coronary dissection, air/debris emboliza-
tion, IVUS entrapment [1,2]). Finally, the utilization of IVUS and OCT
increases signiﬁcantly procedure cost and duration. To overcome
these limitations, enhanced stent visualization (ESV) systems have
been recently developed. ESV systems allow a high-quality real-time
evaluation during stent positioning and they can be useful in the
assessment of stent integrity. ESV images are immediately available
and do not require any user interaction. A balloon catheter with
radiopaque markers must remain in the region of interest to allow
registration and processing of all frames within the acquired
sequence. We performed a review of the available data regarding
ESV systems and we present the main applications of ClearStent Live
system1 (Siemens Healthcare, Munich, Germany) in the manage-
ment of ‘‘tricky’’ PCI cases. In our case series, the images from
ClearStent are integrated with IVUS and OCT imaging, showing
advantages and limits of this ESV system. reserved.
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A 55-year-old man was admitted to our Cath-Lab with
acute myocardial infarction (AMI) complicated by cardiogenic
shock. The admission electrocardiogram  (ECG) showed diffuse
ST-segment depression with ST-segment elevation in aVR lead.
The coronary artery angiography (CAA) showed a complex
critical lesion involving the predivisional left main (LM) coronary
artery. Firstly, we placed two guidewires in the distal left
anterior descending (LAD) and in the left circumﬂex (LCX) artery
and we performed pre-dilation (Trek 3.0 mm  15 mm and
3.5 mm  15 mm, Abbott Vascular, Santa Clara, CA, USA). Then,
a single drug-eluting stent (DES) (Promus Element
4.0 mm  32 mm, Boston Scientiﬁc, Natick, MA, USA) was
implanted in the LM-LAD axis. Afterward, we performed post-
dilation (Quantum Maverick 4.5 mm  15 mm, Boston Scientiﬁc),
proximal optimization technique (POT) and kissing-balloon (KB)
(Quantum Maverick 4.5 mm  15 mm and 3.5 mm  15 mm).
The angiographic result was considered acceptable (Fig. 1A).
Unexpectedly, ClearStent imaging showed a stent fracture
involving the mid-portion of LM (Fig. 1B). The stent fracture
was conﬁrmed by IVUS (Atlantis Pro catheter, Boston Scientiﬁc)
and OCT (ImageWire, LightLab Imaging, Westford, MA, USA)
imaging (Fig. 1C–E). For this reason, another DES (Xience V
4.0 mm  8 mm; Abbott Vascular) was implanted to cover the
fracture with good ﬁnal result, conﬁrmed by ClearStent (Fig. 1F).
Procedure total contrast dye volume was 300 ml (Iobitridol
Xenetix1 350 mg iodine/mL, Xenetix1, Guerbet, Sulzbach,
Germany), total ﬂuoroscopy time was 18 min, and dose area
product (DAP) was 36,000 cGy cm2. At a 1-year follow-up, the
patient was asymptomatic and free from events.Fig. 1.
Combined imaging of stent fracture in the left main (LM) coronary artery. (A) 
fracture involving the mid portion of LM. (C) Stent fracture (intravascular ult
(F) Final result (ClearStent image). Arrows and * indicate stent fracture.Case 2: stent thrombosis with multiple stent fractures and gap
between stents
An 86-year-old male was admitted for ST-segment elevation MI
(STEMI). He had a previous history of recurrent non-ST elevation-
acute coronary syndrome (NSTE-ACS). In the ﬁrst procedure, a DES
was implanted in the proximal segment of right coronary artery
(RCA), while in the second one another DES was placed in the mid
RCA. During primary PCI, CAA showed an acute occlusion of the
mid RCA. ClearStent allowed the visualization of a gap zone
between the two previously implanted stents and multiple stent
fractures (Fig. 2A). The same ﬁndings were conﬁrmed by OCT
imaging (Fig. 2B–E). In order to cover both the gap zone and the
multiple stent fractures, another DES (Promus Premier
4.0 mm  32 mm, Boston Scientiﬁc) was implanted with a good
ﬁnal angiographic result. Procedure total contrast dye volume was
164 ml iodixanol (Visipaque 270, GE Healthcare, Little Chalfont,
UK), total ﬂuoroscopy time was 7.12 min and DAP was
7174 cGy cm2. No complications occurred either during the
hospital stay, or during the follow-up (6 months).
Case 3: ClearStent-guided stent implantation in gap between
two previously implanted stents
A 69-year-old male underwent CAA for worsening effort angina.
Six months before, the patient was treated with implantation of
2 DES (Biomatrix Flex 2.5 mm  24 mm and 3 mm  33 mm,
Biosensors International, Singapore) on LAD because of effort
angina in another hospital. The CAA showed a critical focal in-stent
restenosis (ISR) involving the mid portion of LAD (type IA
according to Mehran’s ISR classiﬁcation [3]). Functional evaluationAngiographic image of LM after stent placement. (B) ClearStent image of the stent
rasound image). (D and E) Stent fracture (optical coherence tomography image).
Fig. 2.
Thrombosis in gap between stents and multiple stent fractures. (A) Gap
between stents and stent fractures (ClearStent image). (B–E) Optical
coherence tomography images. (B) Stent fracture. (C) Stent thrombosis.
(D) Gap between stents. (E) Distal part of the stent without thrombosis.
Fig. 3.
ClearStent-guided stent implantation in gap between two previously
implanted stents.
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Paul, MN, USA) resulted positive (0.73). Within the ISR zone,
ClearStent imaging showed a signiﬁcant gap between the two
previously implanted stents in LAD. ClearStent imaging was used
to guide the deployment of another DES in the gap zone (Fig. 3;
Xience V 3.0 mm  12 mm; Abbott Vascular). A good angiographic
and functional result (post-stenting FFR = 0.93) was obtained.
Procedure total contrast dye volume was 180 ml (Iobitridol
Xenetix1 350 mg Iodine/mL, Xenetix1), total ﬂuoroscopy time
was 20.24 min and DAP was 13,241 cGy cm2. During the follow-up
(9 months), the patient presented no clinical events.
Case 4: stent under-expansion
A 72-year-old man was admitted for STEMI complicated by
cardiogenic shock. Two months before, the patient was treated with
bifurcation stenting of LM (mini-crush technique) with two DES
implantations (Xience V 3.5 mm  28 mm and 3 mm  24 mm) in
another hospital. After intra-aortic balloon pump (IABP) placement,
CAA showed stent thrombosis (ST) of distal LM with occlusion of LCX
and thrombolysis in myocardial infarction (TIMI) ﬂow 2 on LAD
(Fig. 4A). Two guidewires were immediately placed in LCX and LAD
and several predilation and KB were performed (NC Trek
2.5 mm  15 mm and NC Trek 3 mm  15 mm, Abbott Vascular)
with TIMI ﬂow 3 restoration in both LM-LAD and LM-LCX axes
(Fig. 4B). ClearStent image showed the presence of stent under-
expansion in the proximal LCX, due to severe calciﬁcation in theostium of LCX (Fig. 4C). At this stage, considering that TIMI 3 ﬂow
was restored, we decided to suspend the procedure and to
reschedule a second one, after hemodynamic stabilization. Four
days later, the patient underwent the second procedure. IVUS and
OCT images conﬁrmed the stent under-expansion previously shown
by ClearStent (Fig. 4D and E). Laser atherectomy (ELCA Laser
Ablation Catheter 1.7 mm, Spectranetics Corporation, Colorado
Springs, CO, USA) and KB (NC Trek 3.5 mm  15 mm and NC Trek
4 mm  15 mm) were then performed with signiﬁcant LCX expan-
sion and good angiographic and OCT ﬁnal result (Fig. 4F and G).
Procedure total contrast dye volume was 187 ml (Iobitridol
Xenetix1 350 mg Iodine/mL, Xenetix1), total ﬂuoroscopy time
was 30.30 min and DAP was 21,296 cGy cm2. After 6 months the
patient underwent CAA because of atypical chest pain. CAA showed a
good angiographic result of the previous PCI on LM-LAD-LCX. To date
(after 1 year), the patient did not experience any further clinical
problem.
Case 5: stent loss
A 75-year-old man was admitted to our institution for NSTE-
ACS complicated by ventricular ﬁbrillation. Emergency CAA
showed a long disease involving LM-LAD axis and mid LCX with
presence of severe calciﬁcations. Firstly, we decided to treat the
mid LCX and then the LM-LAD axis. We performed several
predilations with different balloons (Tazuna 1.5 mm  15 mm,
Terumo Corporation, Tokyo, Japan; NC Trek 2 mm  15 mm and
2.5 mm  15 mm). During the attempt to deliver a DES (Biomatrix
Flex 2.5 mm  24 mm) in the mid LCX, the stent was initially
entrapped in the calciﬁcations between LM and LCX and then lost.
Two-wires (PT Graphix Intermediate and Choice Extrasupport PT,
Boston Scientiﬁc) and loop snare techniques (Hooker1, Med-Italia
Biomedica s.r.l., Genova, Italy) were used in the attempt to retrieve
the stent. Unfortunately, we only managed to move it from proximal
LCX to LM and, afterwards, to the proximal LAD. All the attempts to
recover the stent failed. At this stage, the mid portion of LCX was
successfully treated with the implantation of a bare metal stent
(Integrity 2.5 mm  22 mm, Medtronic CardioVascular, Santa Rosa,
Fig. 4.
Multi-imaging evaluation of stent under-expansion. (A and B)
Angiographic images. (A) Stent thrombosis of distal left main
coronary artery. (B) Stent under-expansion in proximal left
circumﬂex artery (LCX). (C–E) Severe calciﬁcations and stent under-
expansion in proximal LCX by ClearStent (C), intravascular ultrasound
(D), and optical coherence tomography (OCT) (E). (F and G) Final result
by angiography (F) and OCT (G).
Fig. 5.
Lost stent crushed below another stent. (A) ClearStent image showing
the lost stent crushed in proximal left anterior descending artery.
(B and C) Intravascular ultrasound images. The arrows indicate the lost
stent.
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After further predilation (Tazuna 1.5 mm  15 mm, NC Trek
2 mm  15 mm, 2.5 mm  15 mm and 3 mm  15 mm), the lost
stent was crushed below two DES (Promus Premier 3 mm  32 mm
and 3.5 mm  32 mm) implanted in overlap in the LM-LAD axis. Post-
dilation and KB were performed (NC Trek 3.0 mm  15 mm and
4.0 mm  15 mm). ClearStent and IVUS imaging conﬁrmed adequate
coverage of the lost stent and the good expansion of the stents in the
LM-LAD axis (Fig. 5A–C). Procedure total contrast dye volume was
190 ml (Iobitridol Xenetix1 350 mg Iodine/mL, Xenetix1), total
ﬂuoroscopy time was 18.11 min and DAP was 20,019 cGy cm2. The
patient was discharged on day 6 and there were no clinical events
during the follow-up (18 months).
Discussion
Case reports and case series have validated the use of
StentBoost Subtract System1 (Philips Healthcare, Best, The
Netherlands) and StentViz1 (GE Healthcare, Milwaukee, WI,
USA) in different clinical scenarios (Table 1) [4–8]. Recently,
Achenbach et al. published a case report regarding use of
ClearStent Live System, assessing stent deformation during
bifurcation stenting. Several studies investigated ESV systems in
various settings (Table 1) [9]. Fysal et al. evaluated StentBoostutilization in 8 patients with a dedicated bifurcation stenting
(TrytonTM, Tryton Medical, Durham, NC, USA) [10]. Visibility of
wedding band was considered ‘‘optimal’’ in 7 patients. In 2 cases,
there was incomplete apposition of the stents at the carina.
StentBoost helped in recognizing the issue to achieve full
apposition with post-dilation. In a retrospective study, Blicq
et al. conﬁrmed the usefulness of StentBoost in the detection of
underdeployed stents in 168 consecutive PCI procedures [11]. Silva
et al. prospectively evaluated 97 patients who underwent
bifurcation PCI using StentBoost system [12]. In 79.6% of the
cases they obtained an optimal visualization of the stent struts and
guidewire, while only in 1% they obtained a poor visualization of
the struts or guidewire [12]. A recent retrospective observational
analysis by Oh et al. recruited 870 patients who underwent PCI
with DES with or without StentBoost utilization [13]. At 6 months,
the StentBoost group had signiﬁcantly lower rates of late loss and
binary restenosis [13]. At 12 months, the StentBoost group had
signiﬁcantly lower incidence of target lesion revascularization
(TLR) and TLR-major adverse cardiac events compared with the
no-StentBoost group [13].
In our case-series we used the ClearStent Live system1. All
three ESV systems available on the market have been developed to
enhance stent visualization and all of them need radiopaque
markers to allow registration and processing. At present, there are
no available data regarding head-to-head comparisons between
different ESV systems. However, we can speculate that there are no
signiﬁcant differences between them. As reported above, the main
ESV applications have been stent fracture and/or stent under-
deployment assessment. In our case series, we suggested new
clinical applications (between stents gap assessment, stent loss
evaluation, ST and/or ISR underlying mechanisms evaluation). In
addition, in each case ESV imaging has been performed and
Table 1 Overview of the available data regarding enhanced stent visualization systems.




[7] Ramegowda et al. StentBoost Stent Fracture Case Report No 1
[9] Achenbach et al. ClearStent Bifurcation Stenting Case Report No 1
[8] Roik et al. StentBoost Bifurcation Stenting Case Report No 1
[4] Nazif et al. StentViz Stent Expansion, Stent Fracture in Coronary
Aneurysm
Case Series IVUS 2
[5] Eng et al. StentBoost Understanding Prior Bifurcation Stenting, Stent
Implantation, Stent Underdeployment
Detection, ISR, Coronary Perforation
Containment
Case Series IVUS 6
[6] Mutha et al. StentBoost Stent Implantation, Stent Underdeployment
Detection, Stent Overlap, Understanding Prior
Bifurcation Stenting, Bifurcation Lesions, ISR
Case Series No 10
[11] Blicq et al. StentBoost Stent Underdeployment Detection Retrospective No 168
[13] Oh et al. StentBoost Mid-term Angiographic and Clinical Outcomes Retrospective IVUS 870
[10] Fysal et al. StentBoost Stent Optimization Technique in Dedicated
Bifurcation Stent
Prospective No 8
[12] Silva et al. StentBoost Bifurcation Lesions Prospective No 97
[14] Jin et al. StentBoost Radiation Exposure Prospective No 414
No., number; Ref., reference; ESV, enhanced stent visualization; ISR, in-stent restenosis; IVUS, intravascular ultrasound.
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advantages and drawbacks. ESV systems can be utilized both
alternatively or complementary to more complex intracoronary
imaging techniques (IVUS or OCT). For instance, in IVUS- or OCT-
guided PCI, ESV system can be useful during post-dilation after
stenting or during serial stent implantation. We believe that ESV
systems represent a precious and easy tool for interventional
cardiologists, since they enhance type and quality of information
related to stent placement, expansion, overlapping, and integrity.
Obviously, ESV systems do not provide the same accurate
information obtained with IVUS or OCT. However, they are cost
and time saving and on most occasions may provide the
information needed to achieve good clinical and angiographic
results, even in complex PCI cases. Another advantage of ESV
systems is that images can be obtained without the use of contrast
dye. The main drawback of ESV system use could be the increase in
radiation exposure. This issue has been recently investigated by Jin
et al. in a prospective study [14]. They found that the DAP,
ﬂuoroscopy time, and cine frames were signiﬁcantly increased in
the StentBoost group [14]. Nevertheless, multiple linear regression
showed that StentBoost subtract imaging had no signiﬁcant impact
on patient radiation dose [14]. Our case series may not help in the
clariﬁcation of this issue, but in all our patients ﬂuoroscopy time
and DAP were consistent with the procedure complexity. We did
not observe a signiﬁcant increase in radiation exposure due to ESV
application.
In conclusion, ESV systems can be utilized both along with or
instead of intracoronary imaging techniques during stent implan-
tation, to assess stent expansion, overlapping, and integrity.
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